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Abstract 16 
 17 
The ability to tolerate infection is a key component of host defence and offers potential novel 18 
therapeutic approaches for infectious diseases. To yield successful targets for therapeutic 19 
intervention, it is important that the analytical tools employed to measure disease tolerance are 20 
able to capture distinct host responses to infection. Here, we show that commonly used methods 21 
that estimate tolerance as a linear relationship should be complemented with more flexible, 22 
non-linear estimates of this relationship which may reveal variation in distinct components 23 
such as host vigor, sensitivity to increases in pathogen loads, and the severity of the infection. 24 
To illustrate this, we measured the survival of Drosophila melanogaster carrying either a 25 
functional or non-functional regulator of the JAK-STAT immune pathway (G9a) when 26 
challenged with a range of concentrations of Drosophila C Virus (DCV). While classical linear 27 
model analyses indicated that G9a affected tolerance only in females, a more powerful non-28 
linear logistic model showed that G9a mediates viral tolerance to different extents in both 29 
sexes. This analysis also revealed that G9a acts by changing the sensitivity to increasing 30 
pathogen burdens, but does not reduce the ultimate severity of disease. These results indicate 31 
that fitting non-linear models to host health-pathogen burden relationships may offer better and 32 
more detailed estimates of disease tolerance.   33 
 34 
 35 
Key-words: Infection tolerance; Dose-response curve; Drosophila; Drosophila C Virus; 36 
invertebrate immunity; antiviral response  37 
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Introduction 38 
Disease tolerance is broadly defined as the host’s ability to limit damage and maintain health 39 
when faced with increasing pathogen burdens, and is a general feature of host responses to 40 
infection [1–5]. Identifying mechanisms that underlie host variation in disease tolerance may 41 
therefore offer potentially novel therapeutic targets to treat infections [4,6–8], an approach 42 
already being explored in the context of sepsis [9], HIV [10], influenza [11] and malaria [12]. 43 
The key to understanding tolerance is that it cannot be measured by considering host health or 44 
pathogen growth separately, but is instead defined by their relationship. This idea is embedded 45 
in the original statistical framework of tolerance [13], where it is analysed as a linear reaction 46 
norm of host health measured over a range of increasing infectious doses or pathogen burdens. 47 
Steep negative slopes for this linear relationship describe groups of hosts that experience a loss 48 
in health with increasing loads, while hosts with shallow slopes are able to maintain relatively 49 
higher levels of health even as pathogen loads increase, and are therefore relatively more 50 
tolerant of infection [1–4]. 51 
 52 
While the linear reaction norm approach is intuitive and has been useful in advancing the study 53 
of infection tolerance (reviewed in [14]), in some cases it may be hindering our ability to 54 
achieve a greater mechanistic understanding of the processes underlying host tolerance of 55 
infections. For instance, there is no reason to expect the relationship between host health and 56 
pathogen burdens to be linear [15], and assuming so may be misleading. To circumvent this 57 
problem, a quadratic term in addition to the linear model has occasionally been used to resolve 58 
the nature of this non-linear relationship [10,16]. Following on from quadradic models, 59 
analytical approaches that allow more flexible, non-linear sigmoid relationships between host 60 
health and pathogen burdens - or ‘tolerance curves’  (Fig 1) -  have been proposed [4,7,15]. 61 
One advantage of a sigmoid tolerance curve is that in addition to the rate of health decline with 62 
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increasing infection loads (the slope), it also allows other health parameters to be estimated, 63 
such as host vigour, host sensitivity to increases in pathogen load, and the ultimate severity of 64 
infection, which determines how sick a host can get during infection (Fig 1). For example, a 65 
recent study of disease tolerance fitted a 4-parameter logistic model to the median survival of 66 
Drosophila infected with the bacterial pathogen Listeria monocytogenes, and this allowed to 67 
disentangle changes in fly health during infection that arose due to bacterial pathogenesis and 68 
host immunopathology [15], which would not have been possible using classical linear 69 
analyses. 70 
 71 
Despite these analytical advances, many studies continue to infer tolerance phenotypes from 72 
separate measures of host health and pathogen burdens measured at a single infectious dose 73 
(for example, [11,12,17]). This approach may provide a general indication that groups of hosts 74 
differ in their ability to tolerate infection - for example, when differences in survival are not 75 
accompanied by changes in pathogen loads - but they are less useful at describing the rate of 76 
health loss with increasing pathogen burdens (the very definition of tolerance), and are also not 77 
informative about tolerance at varying infectious doses. This multitude of analytical methods 78 
also makes it difficult to draw general conclusions across studies in different species about the 79 
ability of hosts to tolerate infection, and how this may vary with genotypic and environmental 80 
variation [5,18].  81 
 82 
Using both linear and non-linear analyses, here we examine the tolerance response to a 83 
systemic viral infection in Drosophila melanogaster, which has been used extensively as a 84 
model host to dissect the mechanisms underlying tolerance of bacterial and viral infections 85 
[15,17,19–21]. D. melanogaster infected systemically with Drosophila C Virus (DCV) 86 
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develops pathology in the reproductive and digestive organs, severe abdominal swelling due to 87 
enlargement of the crop  and eventually death [22–24]. An epigenetic regulator of the JAK-88 
STAT pathway, G9a, was previously identified as a mediator of tolerance to RNA virus 89 
infection in D. melanogaster [17]. When exposed to a single lethal dose of DCV, fly mutants 90 
with a dysfunctional G9a showed higher mortality than those with a functional G9a, even 91 
though there was no difference in the viral loads of the two lines measured at a single time 92 
point. This work was notable in providing one of the first examples of immune-mediated 93 
tolerance of RNA virus infection, but because it focused on the functional basis of 94 
hypersensitivity to DCV, it was designed in a way that did not allow a comprehensive 95 
assessment of tolerance. First, infection tolerance was extrapolated from separate analyses of 96 
host mortality and viral loads, providing limited information on the role of G9a on host vigour, 97 
sensitivity to viral growth or the severity of infection that flies can withstand. Further, tolerance 98 
was only measured at a single viral dose, making it unclear if the observed tolerance phenotype 99 
is dose-specific. Finally, this work only assessed the tolerance phenotype of female flies 100 
challenged with a viral infection. Given the prevalence of sexual dimorphism in immunity [25–101 
27], and its expected epidemiological and evolutionary consequences [28,29] it is important to 102 
test if infection tolerance may also vary between sexes.  103 
 104 
We employed systemic infections in both males and females of two Drosophila lines with 105 
identical genetic backgrounds, differing only in having a functional or non-functional G9a 106 
(G9a+/+ and G9 -/-). We challenged these flies with a range of DCV doses and then quantified 107 
their tolerance responses using both the slope of linear reaction norm and a non-linear sigmoid 108 
model. This allowed us to measure infection tolerance in the most comprehensive way, 109 
identifying which components of infection tolerance are affected by a single regulator of fly 110 
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immunity (G9a), while also providing a useful comparison of current methodology to estimate 111 
components of infection tolerance.    112 
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Results  113 
The magnitude of G9a-mediated antiviral protection is dose dependent 114 
Following infection with a range of doses of DCV, we found that overall G9a-/- flies showed 115 
significantly higher mortality compared with G9a+/+(Fig 2a & 2b, Table 1) in line with 116 
previously reported effects of this gene on fly survival [17]. However, we found that G9a+/+ 117 
and G9a-/- responded differently to each viral dose, and that the magnitude of the survival 118 
benefit of having a functional G9a varied with the infectious dose of DCV (Table 1, fly line-119 
by-dose interaction). Notably, mortality was similar between G9a+/+ and G9a-/- when 120 
challenged with the highest dose (109), indicating that the protective effect of a functional G9a 121 
is no longer observed when flies were challenged with very high doses of DCV.   122 
 123 
G9a+/+ and G9a-/- flies exhibit similar DCV viral loads at all infection doses 124 
Overall, female flies achieved higher viral loads measured 5 days post infection compared to 125 
males (Table 2, sex effect). Viral load increased in a dose-dependent manner in both lines 126 
(Table 2, Virus dose effect) and did not differ between the two fly lines across all infection 127 
doses (Fig 2c & 2d, Table 2, line × dose interaction).  128 
 129 
The slope of the linear reaction norm suggests that G9a-mediated tolerance is sex-130 
specific 131 
Given that we found a significant positive relationship between DCV infection dose and the 132 
viral titre (Males: p < 0.0001, r2 = 0.56, Females: p < 0.0001, r2 = 0.64; Fig 2c,d). Differences 133 
in tolerance between G9a+/+ and G9a-/- are indicated by a significant interaction between the 134 
viral dose and the fly line for survival, which reflects that the rate at which survival changes 135 
with increasing viral doses (tolerance) varies between fly lines. We detected a significant 136 
interaction in females (Table 3, Fig 3b), where G9a+/+ females showed higher tolerance (Slope: 137 
8 
 
-1.2 ± 0.4) compared to G9a-/- females (Slope: -1.8 ± 0.3). In males, however, no significant 138 
difference in slopes was detected between G9a+/+ and G9a-/- (Table 3), suggesting that percent 139 
decline in health of G9a+/+ males was comparable to that of G9a-/- (Fig 2a).  140 
 141 
Non-linear models reveal that G9a affects the sensitivity to infection but not its severity 142 
We then analysed the relationship between fly survival and viral dose using a non-linear 4-143 
parameter logistic model [7,15,30]. Using this non-linear model allowed us to assess how G9a 144 
affected the sensitivity of flies during infection and the ultimate severity of DCV infection in 145 
both functional and deficient versions of this regulator of the JAK-STAT pathway (Fig 1). A 146 
comparison of the overall fit of the curves showed that G9a+/+ and G9a-/- genotypes have 147 
distinct tolerance profiles during DCV infection (p < 0.0001, Males: F2, 196 = 14.8, Females: F2, 148 
196 = 50.71). We further used this model and equation 1 to extract parameters - ‘c’ (Inflection 149 
Point: Sensitivity) and ‘a’ (Disease Severity) (Fig. 1).   In contrast to the analysis assuming a 150 
linear relationship, we found that both male and female G9a-/- flies differed from G9a+/+ in 151 
their ability to tolerate DCV (Fig 3c & 3d, Table 4). This non-linear analysis showed that 152 
G9a+/+ flies have a significantly higher inflection point compared to G9a-/- flies, suggesting 153 
that G9a+/+ flies are less sensitive (or more tolerant) to increasing viral doses. The sensitivity 154 
to infection differed by 70-fold between G9a+/+ and G9a-/- in females (p<0.0001) while we 155 
detected a ten-fold difference in males (p<0.0001) (Fig 3e). We did not find any difference 156 
between G9a+/+ and G9a-/- in the severity of infection (Table 4, Fig 3f).  157 
 158 
Lack of G9a leads to sex-specific expression of the JAK-STAT ligand upd3  159 
The differences between G9a-/- males and females in the sensitivity to increasing viral loads 160 
(Fig 3E) prompted us to investigate if this may be due to sex-specific regulation of fly immunity 161 
by G9a. As G9a is known to be an epigenetic regulator of the JAK-STAT pathway, we 162 
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measured the expression of JAK-STAT pathway genes in flies receiving the highest viral 163 
concentration, 5 days following DCV infection (the same day on which viral loads were 164 
quantified). We chose this dose since we detected high viral titres at 5DPI, and were therefore 165 
more likely to detect changes in immune gene expression. We measured the expression of an 166 
extracellular ligand upd3 which is released upon stress or infection, its transmembrane receptor 167 
domeless, a suppressor of JAK-STAT pathway i.e. socs36E, and a stress response element totA. 168 
Both socs36E and totA are downstream regulators of JAK-STAT pathway. Compared to flies 169 
with a functional G9a, G9a-/- mutants showed a significant increase in the expression of the 170 
JAK-STAT ligand upd3, and this effect was stronger in male flies (Fig 4; Table 5). Males 171 
showed generally higher expression of the JAK-STAT receptor domeless, although this effect 172 
was independent of G9a status (Fig 4; Table 5). G9a-/- flies also showed significantly higher 173 
expression of the negative regulator of JAK-STAT, socs36E, but this effect did not differ 174 
between males and females. Finally, we found no effect of either sex or G9a on the expression 175 
or turandotA (totA), which is commonly expressed in response to stress.  176 
 177 
Discussion 178 
Targeting mechanisms that promote greater tolerance of infection is a promising addition to 179 
our current arsenal of strategies to fight infection [3,6–8]. However, if this is to be a successful 180 
undertaking, it is crucial that the analytical tools we use to measure tolerance are able to capture 181 
distinct host responses during infection. A major aim of this study was to evaluate two 182 
analytical methods to measure tolerance (linear reaction norms and non-linear curves), in order 183 
to assess the benefit and limitations of each approach. 184 
Both linear and non-linear models consistently showed that G9a+/+ females have higher 185 
tolerance than G9a-/- females, when measured across a range of DCV doses. However, the two 186 
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models presented different results in the case of males. Additionally, we observed similar 187 
mortality between G9a+/+  and G9a-/-  at the highest dose highlighting the importance of 188 
studying infection at a range of doses, as artificially high infectious doses can mask these 189 
protective effects. 190 
Differences in infection tolerance between groups of hosts are commonly extrapolated from 191 
single infection doses and by performing independent analysis for  host survival and pathogen 192 
burdens [11,12,17]. These experiments are useful in detecting the effect of specific mechanisms 193 
underlying host tolerance, but the limitations of single-dose tolerance experiments arise 194 
because a host’s ability to limit the damage, and therefore tolerate infection, is not necessarily 195 
independent of the within-host pathogen burden it suffers. The approach arising from the 196 
evolutionary ecology of infection, which measures tolerance as a linear reaction norm, provides 197 
additional information, such as an estimate of general vigor from the intercept, while its slope 198 
gives an estimate of the rate of decline in the health [1,14]. While useful, there are at least two 199 
limitations to interpreting infection tolerance as a linear reaction norm. First, there is no 200 
biological requisite for the relationship between pathology and pathogen burdens to be linear 201 
[10,16]. Second, there are statistical caveats associated with measuring differences between 202 
linear slopes when data ranges do not overlap, which is likely if hosts also differ in the mean 203 
and variance of their pathogen loads (the x-axis of the reaction norm) [31,32].   204 
 205 
In this regard, using non-linear sigmoid models offers greater flexibility to fit a range of 206 
possible relationships (including a linear approximation) between host health and pathogen 207 
loads [15]. Moreover, non-linear tolerance curves provide additional information on several 208 
components of host responses to infection, such as the sensitivity and severity of infection. 209 
Differences between groups of hosts in any of the parameters extracted from a non-linear model 210 
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(slope, sensitivity, severity) may therefore reflect distinct underlying mechanisms that either 211 
promote greater damage prevention or increase damage repair during infection [15]. 212 
Employing such methodology to a range of host-pathogen systems may therefore yield useful 213 
targets for therapeutic interventions that increase host disease tolerance [7]. 214 
 215 
We chose to use viral dose instead of viral load as the measure of pathogen burden in our 216 
analysis of tolerance. This approach has the advantage that the covariate (dose) is measured 217 
without error, which is one of the assumptions of ANCOVA, and avoids common problems 218 
with underestimation of slopes in ANCOVAS when there is experimental variance in the 219 
covariate [33]. Using dose as a covariate is also useful in the cases where load is not normally 220 
distributed or when the relationship between pathogen dose and pathogen load is condition-221 
dependent, which could loead to biased tolerance estimates[20].  In the situations when the 222 
correlation between the viral dose and viral load is weak, it would be ideal to use pathogen load 223 
in estimating tolerance.  224 
 225 
Despite all the stated advantages, one potential drawback of using non-linear sigmoid models 226 
to study tolerance is that the slope of health decline is measured over a very small range of 227 
pathogen doses. Accurate estimates of that slope would therefore require many estimates of 228 
host health within a very narrow range of pathogen burdens, which may be experimentally 229 
challenging. For this reason, in the current analysis we fixed the slope to -1, which also 230 
increased the statistical power to estimate the two parameters of interest (sensitivity and 231 
severity). In this respect, we propose that using the linear reaction norm approach could be 232 
useful if the main variable of interest is the rate at which hosts lose health, which is estimated 233 
along the full range of pathogen burdens. Non-linear approaches are more informative if the 234 
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parameter of interest is the dose that causes the greatest shift in host health, or if the question 235 
relates to how hosts may differ in the ultimate severity of an infection. 236 
 237 
A subsidiary interest of this work was to quantify G9a-mediated tolerance of DCV in both male 238 
and female Drosophila. Our results support previous work using a single dose of DCV, which 239 
found that the lower survival of G9a-/- flies was not attributed to differences in their viral load  240 
[17]. Applying the classical linear reaction norm approach, the linear slope showed no 241 
difference in the rate of survival with increasing DCV doses, while the non-linear fit indicated 242 
significant differences between G9a+/+ and G9a-/- males in their sensitivity to infection. Further 243 
analysis of the sensitivity and severity of infection parameters extracted from the non-linear 244 
model also showed that the effect of G9a in mediating host sensitivity to DCV was greater in 245 
females.  Our results therefore show that dysfunctional G9a accelerates the onset of infection-246 
associated mortality (affecting sensitivity), without causing substantial effects on the disease 247 
severity ultimately experienced by infected flies. It is important to note that while previous 248 
work also found G9a-/- females were hypersensitive to DCV infection, this was only assessed 249 
by measuring survival at one dose and infection tolerance was not measured in male flies [17].  250 
 251 
While males and females are generally susceptible to the same pathogens, sexual dimorphism 252 
in immunity is present in a wide range of species [25,34,35], and sex differences in infection 253 
tolerance are documented for all classes of viral, bacterial, fungal and parasitic infections [see 254 
[28] for a review]. Differences between males and females in the ability to tolerate infection 255 
will directly impact on the pathogen loads within hosts, and as a consequence, also affect host 256 
shedding of pathogen transmission stages [36,37]. Sexually dimorphic tolerance is therefore 257 
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predicted to generate potentially important heterogeneity in pathogen spread and evolution 258 
[28].  259 
 260 
The mechanisms underlying sex-specific G9a-mediated effects on infection tolerance are not 261 
clear.  G9a is a histone methyltransferase [38,39], and the protective effect of G9a during viral 262 
infection has been previously shown to be driven by the regulation of the JAK-STAT pathway 263 
[17]. Specifically, G9a is known to alter the methylation state of the positive regulator 264 
domeless, the negative regulator Socs36E and downstream pathway components (TotA, vir-1) 265 
of the JAK-STAT pathway [39]. Fly mutants without a functional G9a show increased 266 
mortality due to immunopathology caused by excessive expression of these downstream genes 267 
[17]. Notably, G9a, domeless and its ligands upd1, upd2 and upd3 are all found on the X-268 
chromosome in Drosophila [40,41]. We hypothesised that these X-linked regulators of fly 269 
innate immunity could underlie the sexually dimorphic tolerance response we observed. 270 
However, while we detected sex differences in the expression of domeless (Fig 4), these effects 271 
were not a consequence of G9a function. Instead we found the largest sex-specific effect on 272 
the expression of the upd3 (Fig 4). Previous work had shown that upd3 expression is higher in 273 
G9a -/- flies, resulting in immunopathology [17].  Our work shows that these effects differ 274 
between sexes and are especially strong in males.  275 
 276 
In summary, we show that G9a mediates tolerance during infection with DCV over a large 277 
range of viral doses and that this response differs between males and females. Our study 278 
therefore places emphasis on the importance of incorporating both males and females in studies 279 
of immunity. Our results also stress that conclusions about disease tolerance will vary 280 
according to the method used to estimate the relationship between host health and pathogen 281 
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burdens. We suggest that a combination of linear and non-linear models is ideal to achieve 282 
estimates of the rate of decline in health following infection but also of subtler components of 283 
hosts’ responses, such as the sensitivity to increases in pathogen loads and the ultimate severity 284 
of disease experienced during infection. Further, these methods are applicable not only to the 285 
declines in health experienced during infection, but could in principle be applied to other 286 
diseases, such as cancer [42]. In general, our understanding of host responses to disease 287 
requires a more complete assessment of resistance and tolerance mechanisms across a range of 288 
genetic and environmental contexts.  289 
Methods 290 
Fly stocks  291 
Experiments were conducted on Drosophila melanogaster mutants G9a+/+  and G9a-/- (also 292 
known as G9aDD2), kindly provided by R. van Rij (Radboud University, Nijmegen, NL). G9a-293 
/- was originally constructed by excision of P-element KG01242 from the 5’ UTR of the gene 294 
on the X-chromosome [17,39]. As a control for the mutant line, a P-element excision line was 295 
generated in the same genetic background with a functional phenotype of G9a, referred to as 296 
G9a+/+.Both fly lines were maintained on standard Lewis Cornmeal medium under standard 297 
laboratory conditions at 25°C, 12h: 12h Light: Dark cycle. 298 
 299 
Generation of experimental flies  300 
To set up the experiment, we collected eggs from 15 males and 15 females of each line, kept 301 
in vials containing 6mL Lewis medium supplemented with dry yeast to encourage egg laying. 302 
We set up ten replicate vials per genotype. Flies were left to oviposit in the vials for 24 hours 303 
before being removed and allowing eggs to develop under standard rearing conditions. To 304 
control the larval density of these flies, egg density was maintained between 80-100 eggs per 305 
15 
 
vial by removing excess eggs when required. Flies emerging from these vials were challenged 306 
with DCV and their mortality post – infection and viral load were measured.  307 
 308 
Virus preparation and titration  309 
Drosophila C virus (DCV) is a ssRNA virus of the family Dicistroviridae. We obtained a viral 310 
stock by amplifying DCV in Drosophila S2 cells as described previously  [43]. Cell 311 
homogenate containing DCV was passed through a sucrose cushion, and the resulting pellet 312 
was suspended in 10mM Tris-HCl (pH 7.3). The virus stock was stored in small aliquots at -313 
80°C until further use. To estimate the viral infection dose, we measured the absolute quantity 314 
of virus in the stock culture using quantitative Real-Time PCR (qRT-PCR). Briefly, an aliquot 315 
of this virus stock was taken to extract RNA using TRI reagent. Total RNA was extracted from 316 
virus stock using Tri Reagent (Ambion), using a Direct-zol RNA miniprep kit, which includes a 317 
DNAse step (Zymo Research), reverse-transcribed with M-MLV reverse transcriptase (Promega) 318 
and random hexamer primers, and then diluted 1:2 with nuclease-free water. The cDNA 319 
synthesis was carried out at 37C for one hour following initial ligation of 5 minutes at 70C. 320 
This cDNA was then serially diluted 10-fold until dilution 10-10. qRT-PCR was performed on 321 
an Applied Biosystems StepOnePlus system using Fast SYBR Green Master Mix (Applied 322 
Biosystems) and DCV primers containing 5’AT-rich flaps 323 
DCV_Forward:  5’AATAAATCATAAGCCACTGTGATTGATACAACAGAC 3’, 324 
DCV_Reverse:5’ AATAAATCATAAGAAGCACGATACTTCTTCCAAACC 3’ ). The 325 
reaction conditions used were: 95C for 2 minutes followed by 40 cycles of 95C for 10 326 
seconds and 60C for 30 seconds. The first dilution where no viral cDNA was detected was 327 
taken as zero, and stock viral quantity was back calculated from this reference point. Using this 328 
method, viral copy number in the stock was estimated to be around 109 DCV IU/ml.  329 
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Virus infection  330 
We exposed experimental flies to 5 viral concentrations – 0 (control), 106, 107, 108, and 109 331 
DCV IU/ml, obtained by diluting the viral stock with 10mM Tris-HCl (pH 7.3). Flies were 332 
infected systemically by intra-thoracic pricking with a needle immersed in DCV suspension 333 
under light CO2 anesthesia. The effect of injury caused by pricking was controlled by including 334 
sham-infections performed using a needle dipped in sterile10mM Tris-HCl (pH 7.3).  335 
Experimental set-up 336 
 (a) Post-infection survival. 3-4-day-old adults were systemically infected by intra-thoracic 337 
pricking with DCV. For each Fly line × Sex × Dose combination, we infected 20 replicate 338 
individual flies (400 flies in total). Following infection, flies were housed individually in a vial 339 
and flies were monitored daily for mortality. Flies were transferred onto fresh medium once a 340 
week. Survivorship was followed for 25 days post-infection and flies that were still alive at the 341 
end were censored in the analysis.  342 
(b) Viral Load. An additional five individuals for each Genotype × Sex × Dose combination 343 
were infected as described above to quantify differences in viral growth following infection, 344 
using the expression of DCV RNA. Flies were individually placed in TRI reagent (Ambion) 345 
following five days of infection (5 DPI) and stored at -80C. Total RNA was extracted from 346 
flies homogenised in Tri Reagent and exactly same protocol was followed as described 347 
previously in the section (Virus Preparation and Titration). The expression of DCV transcripts 348 
was normalized to transcript levels of the housekeeping gene rp49 (Dmel_rp49 Forward: 5’ 349 
ATGCTAAGCTGTCGCACAAATG 3’ ; Dmel_rp49 Reverse: 5’ 350 
GTTCGATCCGTAACCGATGT 3’) and expressed as fold change relative to the control flies, 351 
calculated as 2-Ct [44]. 352 
(c) Gene Expression. Using the same cDNA samples described above, we measured the 353 
expression of immune genes likely to be affected a G9a deletion, to test for genotype-specific 354 
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and/or sex-specific differences upon infection. Given that G9a is a regulator of the JAK-STAT 355 
pathway, we focussed on measuring the expression of the extracellular ligand upd3, its 356 
transmembrane receptor domeless, and downstream regulators socs36E, and totA. Gene 357 
expression was quantified in flies exposed to the highest dose treatment (109) relative to their 358 
expression in uninfected controls, as we expected the strongest effects on gene expression to 359 
be detected under elevated viral challenge.  360 
 361 
Statistical Analysis  362 
To analyze differences in survival of each host line according to the virus dose they were 363 
challenged with, we analyzed post-infection survival data using a Cox proportional hazards 364 
model with ‘Fly line’, ‘Dose’ and ‘Sex’ and their interactions, fitted as fixed effects. To assess 365 
differences in viral titers following infection with infection doses, we analysed the Log10 viral 366 
titer measured at 5DPI using ANCOVA and fitted ‘Fly line’ and ‘Sex’ as categorical fixed 367 
effects, ‘Dose’ as a continuous covariate and and their interactions as fixed effects. All the non-368 
significant interactions were removed, and the minimal model was used to estimate correlation 369 
coefficient between Viral load and Viral Dose. 370 
We tested for differences in infection tolerance between fly lines in two ways. First, we use the 371 
classical approach and analyzed tolerance as a linear reaction norm [20,45,46]. A general linear 372 
model was fitted separately for males and females to study the effect of ‘viral dose’ and ‘fly 373 
line’ on fly health i.e. fly survival (DPI). In this analysis ‘viral dose’ was treated as a continuous 374 
covariate and ‘fly line’ as a categorical factor. Given that infection tolerance refers to the rate 375 
at which hosts lose health with increasing viral loads, the analysis of interest is how the slope 376 
of the two fly lines differs, that is, if survival is significantly affected by the ‘fly line-by-viral 377 
load’ interaction. 378 
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As a second approach to quantify infection tolerance, we fitted a non-linear 4-parameter 379 
logistic model (Eqn. 1) which is commonly used to assess dose-response curves [15,30,47] to 380 
the survival and virus dose data. We compared the fit of this model to other models (listed in 381 
Table 6) and found the 4-parameter logistic model outperformed other models, especially the 382 
linear model, based on AICc scores  (Table 6).  383 
Using GraphPad Prism v6.0, we therefore fitted a 4-parameter logistic model described by the 384 
following equation: 385 
𝑦 = 𝑎 +
𝑏−𝑎
1+10[(𝑐−𝑥)𝑠]
     Eqn. 1 386 
where a is the level of disease severity, b is a host’s general vigour, c is the sensitivity to 387 
increases in pathogen dose (in this case, the pathogen dose that results in the level of health 388 
halfway between the min and max health, similar to EC50), s is the slope of the logistic model, 389 
and x is the pathogen dose. Since the experiment was terminated 25 days post-infection, we 390 
constrained the upper limit of the model (host vigour) to 25 (DPI) (see also [15]). To test if 391 
these tolerance curves differed between fly lines, we compared the overall fit of the curves 392 
using extra sum-of-squares F-test [48]. Using these fitted models, we also examined if lines 393 
differed in their sensitivity and disease severity, after fixing the slope to -1. To test for 394 
differences in the severity and sensitivity to infection between male/female groups, or between 395 
G9a lines, we carried out two-way ANOVA with Line and Sex as fixed effects, using Tukey’s 396 
HSD as a post-hoc analysis of pairwise comparisons. Unless otherwise stated, all analyses were 397 
carried out in JMP 12 (SAS). 398 
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Tables 542 
 543 
Table 1:  Summary of Cox Proportional Hazards Model 
studying the effect of Fly Line, Dose, and Sex on Post-Infection 
survivorship 
 
Source DF  p - value 
Fly Line 1 54.81 <.0001* 
Dose 4 225.54 <.0001* 
Sex 1 0.06 0.81 
Fly Line × Dose 4 19.79 0.0005* 
Fly Line × Sex 1 0.40 0.53 
Dose × Sex 4 11.11 0.03* 
Fly Line × Dose × Sex 4 5.33 0.26 
    
 
Table 2: Summary of three-way ANOVA studying the effect of 
Fly line, Viral Dose, and Sex on Viral Load 
Source DF F-ratio p - value 
Fly Line 1 0.49 0.48 
Sex 1 11.73 0.001 
log10 (Viral dose) 1 109.03 <.0001 
Fly Line × Sex 1 0.01 0.91 
Fly Line × log10 (Viral dose) 1 0.52 0.48 
Sex × log10 (Viral dose) 1 0.14 0.71 
Fly Line × Sex × log10 (Viral dose) 1 0.17 0.68 
 544 
Table 3: Linear tolerance: General Linear Model studying effect of Fly 
line and Viral Dose on post-infection survivorship in males and females 
 
Sex Source DF F-ratio p - value 
Males 
Fly Line 1 17.48 <.0001 
log10 (Viral dose) 1 75.82 <.0001 
Fly Line × log10 (Viral dose) 1 0.65 0.42 
Females 
Fly Line 1 47.26 <.0001 
log10 (Viral dose) 1 122.69 <.0001 
Fly Line × log10 (Viral dose) 1 5.64 0.02 
 545 
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 546 
Table 4 – Parameters of a 4-parameter logistic model: Summary of results of two-way 
ANOVA studying the effect of Line, Sex, and Line-by-Sex interaction on Sensitivity 
and Disease Severity. 
           
Parameter 
Source 
df 
Numerator 
df 
Denominator 
F-
ratio 
p value 
Sensitivity 
Fly Line 1 392 89.1 <0.0001 
Sex 1 392 33.54 <0.0001 
Fly Line × Sex 1 392 7.5 0.007 
Disease severity 
Fly Line 1 392 0.03 0.85 
Sex 1 392 1.6 0.21 
Fly Line × Sex 1 392 0.52 0.47 
 547 
 548 
Table 5 – Effect of fly line and sex on JAK-STAT immune gene expression – Summary of 549 
results from two-way ANOVA studying the effect of Fly Line and Sex on the gene 550 
expression  551 
Gene Source DF F Ratio p-value 
upd 3 
Sex 1 8.362 0.012 
Fly Line 1 12.995 0.003 
Fly Line × Sex 1 4.712 0.048 
domeless 
Sex 1 5.101 0.038 
Fly Line 1 0.295 0.595 
 Fly Line × Sex 1 0.897 0.358 
socs36E 
Sex 1 1.577 0.227 
Fly Line 1 9.009 0.009 
 Fly Line × Sex 1 0.343 0.566 
totA 
Sex 1 1.738 0.206 
Fly Line 1 0.306 0.588 
 Fly Line × Sex 1 2.883 0.109 
 552 
 553 
 554 
 555 
Table 6 – Summary of AIC results for models fitting the data for estimating tolerance 556 
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 557 
Sex Model AICc AICc Weight AICc R-Square 
Female 
Logistic 4P 1221.34 0.83 0 0.63 
Logistic 5P 1225.04 0.13 3.70 0.63 
Quadratic 1227.61 0.04 6.26 0.61 
Logistic 3P 1231.03 0.01 9.69 0.61 
Linear 1285.51 9.64E-15 64.17 0.47 
Male 
Logistic 3P 1219.32 0.68 0 0.59 
Logistic 4P 1222.17 0.16 2.85 0.59 
Quadratic 1222.64 0.13 3.32 0.58 
Logistic 5P 1226.03 0.02 6.71 0.59 
Linear 1312.77 3.48E-21 93.45 0.32 
 558 
Table 6 – Summary of AIC results for models fitting the data for estimating tolerance. 559 
For each model fitted to the dose response data, we report the AICc as a measure of the 560 
goodness of fit to the data. The AICc weight can be interpreted as the probability that model is 561 
the best model among the fitted models. AICc were calculated as AICc = AICc(i) – AICcmin.. 562 
R-Square shows the proportion of the variance response that is explained by each model. For 563 
ease of comparison between males and females, we opted to use the 4 parameter logistic model, 564 
as this was the best model for female data, and in males the difference between the AICc for 565 
the  3-parameter and 4 parameter models was negligible and the R-Square identical. 566 
  567 
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Figure legends 568 
 569 
 570 
Fig 1. A diagram of how a 4-parameter logistic model can be used to estimate different 571 
components of host infection tolerance showing host vigor (b), the sensitivity (c), slope (s), or 572 
severity of the dose-response curve (a) [7,15]. 573 
 574 
  575 
Figure'1
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576 
Fig 2. Survival of male (2A) and female (2B) flies challenged with increasing doses of DCV 577 
through systemic infection. G9a+/+ flies are shown in solid lines and G9a-/- mutants are 578 
shown in broken lines. Survival was recorded until day 25 post-infection. Each data point is 579 
the proportion of 20 individual flies per line / sex / dose combination, and was analysed with 580 
a Cox proportional hazard model (Table 1). The DCV titres measured in male (2C) or female 581 
(2D) flies exposed to the same DCV doses, 5 days following systemic infection, for G9a+/+  582 
(black) and G9a-/- (red) lines. Each data point shows the expression of DCV RNA in 583 
individual flies relative to the expression of rp49, a fly control gene. Lines show there is a 584 
significant linear relationship between the doses of DCV flies were challenged with and the 585 
viral titre measured after 5 days (details in text and Table 2).  586 
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 587 
Fig 3. A comparison of linear and non-linear methods to measure infection tolerance in 588 
G9a+/+ (black) and G9a-/- (red) lines. The relationship between host survival and viral dose 589 
analysed using linear models for males (2A) and females (2B) or non-linear 4-parameter 590 
logistic models for males (2C) and females (2D). Each plot shows individual data for 20 591 
individual flies per line / sex/ dose combination. Fig 2E and 2F show the mean and 95% 592 
confidence intervals for sensitivity and disease severity, respectively, extracted from the non-593 
linear models.  Significant pairwise differences are indicated with an asterisk and linear and 594 
non-linear model details are reported in the main text and in Tables 3 and 4.  595 
 596 
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597 
Fig 4. Expression of JAK-STAT immune genes. Gene expression relative to the internal 598 
control gene rp49 was quantified in five replicate individual male and female flies exposed to 599 
the highest dose treatment (109) relative to their expression in uninfected controls. Data show 600 
mean±SE. See table 5 for statistical analysis output. The pairwise-comparisons with significant 601 
differences are highlighted using asterisks. 602 
